93 related articles for article (PubMed ID: 1387587)
1. Multiple secretion of matrix serine proteinases by human gastric carcinoma cell lines.
Koshikawa N; Yasumitsu H; Umeda M; Miyazaki K
Cancer Res; 1992 Sep; 52(18):5046-53. PubMed ID: 1387587
[TBL] [Abstract][Full Text] [Related]
2. Fibronectin degradation by human gastric carcinoma cell lines and its associated proteases in relation to stromal invasion in nude mice.
Wakabayashi H; Kawaguchi T
Invasion Metastasis; 1992; 12(5-6):284-300. PubMed ID: 1298740
[TBL] [Abstract][Full Text] [Related]
3. Pericellular substrates of human mast cell tryptase: 72,000 dalton gelatinase and fibronectin.
Lohi J; Harvima I; Keski-Oja J
J Cell Biochem; 1992 Dec; 50(4):337-49. PubMed ID: 1469068
[TBL] [Abstract][Full Text] [Related]
4. Plasminogen activator mediated degradation of subendothelial extracellular matrix by human squamous carcinoma cell lines.
Niedbala MJ; Sartorelli AC
Cancer Commun; 1990; 2(5):189-99. PubMed ID: 2142433
[TBL] [Abstract][Full Text] [Related]
5. Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane.
Liotta LA; Goldfarb RH; Brundage R; Siegal GP; Terranova V; Garbisa S
Cancer Res; 1981 Nov; 41(11 Pt 1):4629-36. PubMed ID: 6458354
[TBL] [Abstract][Full Text] [Related]
6. Mouse trophoblastic cell lines: II--Relationship between invasive potential and proteases.
Sharma RK
In Vivo; 1998; 12(2):209-17. PubMed ID: 9627804
[TBL] [Abstract][Full Text] [Related]
7. Characterization of matrix-degrading proteinases and their inhibitors secreted by human gynecological carcinoma cells.
Miyagi E; Yasumitsu H; Hirahara F; Minaguchi H; Koshikawa N; Miyazaki K; Umeda M
Jpn J Cancer Res; 1995 Jun; 86(6):568-76. PubMed ID: 7622422
[TBL] [Abstract][Full Text] [Related]
8. Extracellular matrix production and degradation by adenoid cystic carcinoma cells: participation of plasminogen activator and its inhibitor in matrix degradation.
Shirasuna K; Saka M; Hayashido Y; Yoshioka H; Sugiura T; Matsuya T
Cancer Res; 1993 Jan; 53(1):147-52. PubMed ID: 8380125
[TBL] [Abstract][Full Text] [Related]
9. Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants.
Mazzieri R; Masiero L; Zanetta L; Monea S; Onisto M; Garbisa S; Mignatti P
EMBO J; 1997 May; 16(9):2319-32. PubMed ID: 9171346
[TBL] [Abstract][Full Text] [Related]
10. Membrane type I-matrix metalloproteinase-mediated degradation of type I collagen by oral squamous cell carcinoma cells.
Aznavoorian S; Moore BA; Alexander-Lister LD; Hallit SL; Windsor LJ; Engler JA
Cancer Res; 2001 Aug; 61(16):6264-75. PubMed ID: 11507081
[TBL] [Abstract][Full Text] [Related]
11. Characterization of plasminogen activator from two human renal carcinoma cell lines.
Nelson NF; Cieplak W; Dacus SC; Prager MD
J Cell Physiol; 1986 Mar; 126(3):435-43. PubMed ID: 2419348
[TBL] [Abstract][Full Text] [Related]
12. Expression of metalloproteinases and metalloproteinase inhibitors by fetal astrocytes and glioma cells.
Apodaca G; Rutka JT; Bouhana K; Berens ME; Giblin JR; Rosenblum ML; McKerrow JH; Banda MJ
Cancer Res; 1990 Apr; 50(8):2322-9. PubMed ID: 2156617
[TBL] [Abstract][Full Text] [Related]
13. Chemotaxis and haptotaxis of human malignant mesothelioma cells: effects of fibronectin, laminin, type IV collagen, and an autocrine motility factor-like substance.
Klominek J; Robért KH; Sundqvist KG
Cancer Res; 1993 Sep; 53(18):4376-82. PubMed ID: 8364933
[TBL] [Abstract][Full Text] [Related]
14. Tumor promoter-stimulated Mr 92,000 gelatinase secreted by normal and malignant human cells: isolation and characterization of the enzyme from HT1080 tumor cells.
Moll UM; Youngleib GL; Rosinski KB; Quigley JP
Cancer Res; 1990 Oct; 50(19):6162-70. PubMed ID: 2169335
[TBL] [Abstract][Full Text] [Related]
15. Purification and characterization of extracellular matrix-degrading metalloproteinase, matrin (pump-1), secreted from human rectal carcinoma cell line.
Miyazaki K; Hattori Y; Umenishi F; Yasumitsu H; Umeda M
Cancer Res; 1990 Dec; 50(24):7758-64. PubMed ID: 2253219
[TBL] [Abstract][Full Text] [Related]
16. Secretion of extracellular matrix-degrading proteinases is increased in epithelial ovarian carcinoma.
Moser TL; Young TN; Rodriguez GC; Pizzo SV; Bast RC; Stack MS
Int J Cancer; 1994 Feb; 56(4):552-9. PubMed ID: 8112891
[TBL] [Abstract][Full Text] [Related]
17. Latent collagenase and gelatinase from human neutrophils and their activation.
Tschesche H; Knäuper V; Krämer S; Michaelis J; Oberhoff R; Reinke H
Matrix Suppl; 1992; 1():245-55. PubMed ID: 1480034
[TBL] [Abstract][Full Text] [Related]
18. Retinoic acid modulates extracellular urokinase-type plasminogen activator activity in DU-145 human prostatic carcinoma cells.
Waghray A; Webber MM
Clin Cancer Res; 1995 Jul; 1(7):747-53. PubMed ID: 9816041
[TBL] [Abstract][Full Text] [Related]
19. Kupffer cell-derived 95-kd type IV collagenase/gelatinase B: characterization and expression in cultured cells.
Winwood PJ; Schuppan D; Iredale JP; Kawser CA; Docherty AJ; Arthur MJ
Hepatology; 1995 Jul; 22(1):304-15. PubMed ID: 7601425
[TBL] [Abstract][Full Text] [Related]
20. Expression of heterogeneous profiles of plasminogen activators and plasminogen activator inhibitors by human glioma lines.
Sitrin RG; Gyetko MR; Kole KL; McKeever P; Varani J
Cancer Res; 1990 Aug; 50(16):4957-61. PubMed ID: 2379161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
